Welcome to LookChem.com Sign In|Join Free
  • or
7-(TrifluoroMethyl)-3,4-dihydro-1H-quinoxalin-2-one is a chemical compound belonging to the quinoxaline family, characterized by a fused bicyclic structure. It features a quinoxaline core with a 3,4-dihydro configuration, indicating the presence of a saturated ring. The molecule is further distinguished by the presence of a trifluoromethyl group (-CF3) at the 7-position, which imparts unique electronic and steric properties. 7-(TrifluoroMethyl)-3,4-dihydro-1H-quinoxalin-2-one is of interest in medicinal chemistry and materials science due to its potential applications in the development of pharmaceuticals and as a building block for more complex organic molecules. Its synthesis and reactivity are areas of ongoing research, with the aim of exploring its properties and potential uses in various fields.

716-81-4

Post Buying Request

716-81-4 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

716-81-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 716-81-4 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 7,1 and 6 respectively; the second part has 2 digits, 8 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 716-81:
(5*7)+(4*1)+(3*6)+(2*8)+(1*1)=74
74 % 10 = 4
So 716-81-4 is a valid CAS Registry Number.

716-81-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name 7-(trifluoromethyl)-3,4-dihydro-1H-quinoxalin-2-one

1.2 Other means of identification

Product number -
Other names 3,4-dihydro-7-trifluoromethyl-2(1H)-quinoxalinone

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:716-81-4 SDS

716-81-4Downstream Products

716-81-4Relevant academic research and scientific papers

Solid-phase traceless synthesis of selected nitrogen-containing heterocyclic compounds. The encore technique for directed sorting of modular solid support

Krchnak, Viktor,Smith, Jennifer,Vagner, Josef

, p. 1078 - 1106 (2001)

The acid lability of electron-rich N-benzylanilines has been exploited in a linker for the traceless solid-phase synthesis of benzimidazoles, 2-aminobenzimidazoles, quinoxalinones and tetrahydroquinoxalines. The target compound precursors were assembled o

A solid phase traceless synthesis of quinoxalinones

Krchňák, Viktor,Szabo, Lajos,Vágner, Josef

, p. 2835 - 2838 (2000)

A solid-phase traceless synthesis of quinoxalinones in three combinatorial steps is reported. An aldehyde functionalized polystyrene resin was reductively alkylated by amino acid methyl esters, and then the resin bound secondary amines were reacted with o

A Combination of Visible-Light Organophotoredox Catalysis and Asymmetric Organocatalysis for the Enantioselective Mannich Reaction of Dihydroquinoxalinones with Ketones

Rostoll-Berenguer, Jaume,Blay, Gonzalo,Mu?oz, M. Carmen,Pedro, José R.,Vila, Carlos

supporting information, p. 6011 - 6015 (2019/08/26)

An enantioselective photooxidative Mannich reaction of dihydroquinoxalinones with ketones by the merger of organophotoredox and asymmetric organocatalysis is described. This protocol features very mild reaction conditions using simple and cheap catalysts (Eosin Y and (S)-Proline) for the synthesis of chiral quinoxaline derivatives with good to high yields (up to 94%) and excellent enantioselectivities (up to 99% ee).

Synthesis and biological evaluation of N4-(hetero)arylsulfonylquinoxalinones as HIV-1 reverse transcriptase inhibitors

Xu, Bailing,Sun, Yan,Guo, Ying,Cao, Yingli,Yu, Tao

experimental part, p. 2767 - 2774 (2009/08/15)

A series of novel N4-(hetero)arylsulfonylquinoxalinone derivatives were prepared in a straight and efficient way. Of all the synthesized compounds, five compounds exhibited potent anti-HIV-1 replication activities with IC50 value at

Quinoxaline compounds as hypnotic agents

-

, (2008/06/13)

The present invention is concerned with the use of certain quinoxaline compounds as hypnotic agents.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 716-81-4